Qbic

Qbic, established in 2012 and headquartered in St-Denijs-Westrem, Belgium, is a venture capital fund focused on early-stage investments, particularly in spin-offs from universities, research institutions, and hospitals. The fund supports startups in sectors such as deeptech, biotech, medtech, and software. Qbic has made significant contributions to transforming technological breakthroughs into sustainable businesses. Notable investments by Qbic include Theratrame, which focuses on cancer therapies, Animab, which develops alternatives to antibiotics for animals, and VoxelSensors, which specializes in 3D perception sensors for extended reality applications. Additionally, their portfolio includes companies like AmphiStar in the biotechnology field and Weave.ly in software development. Qbic manages around €200 million across its various funds, with Qbic III recently raising €88.5 million to continue supporting innovative spin-offs. The fund's strategic partners include major Belgian universities and research institutions, providing a strong pipeline of high-potential startups. The team at Qbic, led by Managing Partner Sofie Baeten, is dedicated to fostering technological innovation and supporting the growth of their portfolio companies.